NHMRC backs Monash Institute of Pharmaceutical Sciences projects with $7.8m in funding

Dr Dana Hutchinson, Professor Erica Sloan, Associate Professor Karen Gregory, Dr Carlo Giannangelo, Associate Professor Cornelia Landersdorfer

L-R top row: Dr Dana Hutchinson, Professor Erica Sloan, Associate Professor Karen Gregory. L-R bottom row: Dr Carlo Giannangelo, Associate Professor Cornelia Landersdorfer.

18 December 2024

Five projects led by the Monash Institute of Pharmaceutical Sciences (MIPS) have been awarded funding through the National Health and Medical Research Council (NHMRC) Ideas Grants scheme, worth $7.8 million.

The Ideas Grant scheme supports innovative and creative research projects addressing a specific question in any health and medical research area from discovery to implementation for researchers at all career stages.

The successful MIPS projects seek to solve problems across a diverse range of diseases including obesity and type 2 diabetes; psychiatric disorders; malaria; drug-resistant bacterias and cancer.

Director of MIPS, Professor Chris Porter, welcomed the funding and said the projects all aim to address unmet medical needs among some of the most prevalent health burdens across the globe.

“On behalf of MIPS I would like to extend my warm congratulations to the successful NHMRC Ideas grant recipients. Their projects are a prime example of the innovative and creative research required to advance new knowledge and outcomes across multiple areas of disease,” Professor Porter said.

Funded projects include:

Project TitleResearcherFunding
Impact of biased agonism at the GLP-1R in the treatment of obesity and type 2 diabetes

Dr Dana Hutchinson

$2,488,624.03

Sensory-sympathetic neural crosstalk regulates the tumour microenvironment

Professor Erica Sloan

$1,606,948.76

Dissecting the genetic diversity and therapeutic potential in targeting trace amine receptor 1 for psychiatric disorders

Associate Professor Karen Gregory

$1,446,409.00

Discovery of New Antimalarials with a Novel Mechanism of Action and Irresistible Target

Dr Carlo Giannangelo

$1,164,771.50

Optimising dosing strategies with new antibiotics against drug-resistant bacteria

Associate Professor Cornelia Landersdorfer

$1,091,288.97

For more information about the Ideas Grants, visit the NHMRC website.

To read about other successful Monash recipients visit Monash News.

ENDS